Any person, 16 years and over, presenting with shortness of breath or flu-like illness.
This protocol is intended to be used by registered and enrolled nurses within their scope of practice and as outlined in The Use of Emergency Care Assessment and Treatment Protocols (PD2024_011). Sections marked triangle or diamond indicate the need for additional prerequisite education prior to use. Check the medication table for dose adjustments and links to relevant reference texts.
If the patient has:
- signs of anaphylaxis, switch to anaphylaxis or allergic reactions protocol
- asthma, switch to shortness of breath with a history of asthma protocol
- chronic obstructive pulmonary disease, switch to shortness of breath with a history of chronic obstructive pulmonary disease protocol
- cardiac history, switch to shortness of breath with a history of cardiac disease protocol.
History prompts, signs and symptoms
These are not exhaustive lists. Maintain an open mind and be aware of cognitive bias.
History prompts
- Presenting complaint
- Onset of symptoms
- Triggers, including breathlessness on exertion
- Recent illness
- Pain assessment – PQRST
- Pre-hospital treatment
- Past admissions
- Medical and surgical history, including immobility, pulmonary embolism, DVT or ICU intubations
- Current medications
- Known allergies
- Recent travel, including at altitudes or diving (SCUBA)
- Recent contact with sick persons
- Smoking history
Signs and symptoms
- Respiratory distress
- Tachypnoeic
- Cough or haemoptysis
- Sore throat
- Runny nose
- Hypoxia
- Abnormal breath sounds
- Palpitations
- Fatigue
- Anxiety
- Fever
Red flags
Recognise: identify indicators of actual or potential clinical severity and risk of deterioration.
Respond: carefully consider alternative ECAT protocol. Escalate as per clinical reasoning and local CERS protocol, and continue treatment.
Historical
- Known or suspected foreign body aspiration
- Malignancy
- Pregnant or postpartum (3/12)
- Previous history of intubation or ICU admission
- Recent long-haul travel
- Unresponsive to pre-hospital management
- Anaphylaxis
Clinical
- Altered level of consciousness
- Tripod positioning
- Oropharyngeal swelling
- Stridor
- Severe respiratory distress
- Talking in words only
- Bradypnoea
- Silent chest
- Cyanosis
- Chest pain
- Pre-syncope
- Cardiac arrythmia
- Fever
- Urticarial rash
Remember adult at risk: patient or carer concern, frailty, multiple comorbidities or unplanned return.
Clinical assessment and specified intervention (A to G)
If the patient has any Yellow or Red Zone observations or additional criteria (as per the relevant NSW Standard Emergency Observation Chart), refer and escalate as per local CERS protocol and continue treatment.
Position
Assessment | Intervention |
---|---|
General appearance/first impressions | Position of comfort Preferably semi-reclined or upright |
Airway
Assessment | Intervention |
---|---|
Patency of airway | Maintain airway patency Consider airway opening manoeuvres and positioning |
Breathing
Assessment | Intervention |
---|---|
Respiratory rate and effort Auscultate chest (breath sounds) Oxygen saturation (SpO2) | Assist ventilation, as clinically indicated Consider oxygen if dyspnoeic, titrate oxygen to maintain SpO2 over 93% |
Circulation
Assessment | Intervention |
---|---|
Perfusion (capillary refill, skin warmth and colour) Pulse Blood pressure Cardiac rhythm | Assess circulation Attach cardiac monitor and complete 12 lead ECG if BP/HR are within the Yellow or Red Zones, or where clinically relevant, e.g. irregular pulse, palpitations, syncope, shock, respiratory compromise, cardiac history or clinical concern If audible respiratory crepitation and raised JVP and/or peripheral oedema, switch to shortness of breath with a history of cardiac disease protocol |
IVC and/or pathology | Insert IV cannula, if trained If unable to obtain IV access, consider intraosseous, if trained |
Signs of shock: tachycardia and CRT 3 seconds and over and/or abnormal skin perfusion and/or hypotension | If signs of shock present and/or SBP less than 90 mmHg, give 250 mL of sodium chloride 0.9% IV/intraosseous bolus Repeat every 10 minutes (up to 1000 mL) until SBP over 90 mmHg or signs of shock have resolved If patient meets sepsis criteria, switch to sepsis (suspected) protocol |
Disability
Assessment | Intervention |
---|---|
ACVPU | If ACVPU shows reduced level of consciousness, continue to GCS, pupillary response and limb strength |
GCS, pupillary response and limb strength | Obtain baseline and repeat assessment, as clinically indicated |
Pain | Assess pain. If indicated, give early analgesia as per analgesia section then resume A to G assessment |
Exposure
Assessment | Intervention |
---|---|
Temperature | Measure temperature |
Skin inspection, including posterior surfaces | Check and document any abnormalities |
Fluids
Assessment | Intervention |
---|---|
Hydration status: last ate, drank, bowels opened, passed urine or vomited | Commence fluid balance chart, as required |
Nausea and/or vomiting | If present, see nausea and/or vomiting section |
NBM | Consider clear fluids or NBM based on red flags and clinical severity |
Glucose
Assessment | Intervention |
---|---|
BGL | Measure BGL, if clinically indicated If less than 4 mmol/L, consider hypoglycaemia protocol |
Repeat and document assessment and observations to monitor responses to interventions, identify developing trends and clinical deterioration. Escalate care as required according to the local CERS protocol.
Focused assessment
Complete cardiovascular focused assessment.
Complete respiratory focused assessment.
Precautions and notes
- Common life-threatening causes of SOB that should be considered include, but are not limited to:
- ACS
- pulmonary oedema
- arrhythmia
- pulmonary embolism
- anaphylaxis
- pneumonia
- COPD
- sepsis
- angioedema
- pneumothorax
- haemothorax
- acute renal failure
- anaemia
- epiglottitis
- Consider using alternate protocol once further history and assessment are obtained.
- Isolate patients and use appropriate PPE when attending potentially infective patients.
Interventions and diagnostics
Specific treatment
If wheeze is present or quiet breath sounds, consider shortness of breath with a history of asthma protocol.
If ineffective respiratory effort, consider non-invasive ventilation where available and escalate as per local CERS protocol if required.
Analgesia
Select pain score:
Pain score 1–3 (mild)
Give paracetamol 1000 mg orally once only
and/or ibuprofen 400 mg orally once only
Pain score 4–6 (moderate)
Give:
oxycodone (immediate release):
- 16–65 years: 5 mg orally and, if required, repeat once after 30 minutes, maximum dose 10 mg
- 65 years and over: 2.5 mg orally and, if required, repeat once after 30 minutes, maximum dose 5 mg
and/or paracetamol 1000 mg orally once only
and/or ibuprofen 400 mg orally once only
Pain score 7–10 (severe)
Give one of:
Fentanyl intranasal
- 16–65 years: 50 microg intranasally and, if required, repeat once after 5 minutes, maximum dose 100 microg. Dose to be divided between nostrils
- 65 years and over: 25 microg intranasally and, if required, repeat once after 5 minutes, maximum dose 50 microg. Dose to be divided between nostrils
Note: ensure an extra 0.1 mL is drawn up for the first dose to account for the dead space in the mucosal atomiser device
Fentanyl IV
- 16–65 years: 50 microg IV and, if required, repeat once after 5 minutes, maximum dose 100 microg
- 65 years and over: 25 microg IV and, if required, repeat once after 5 minutes, maximum dose 50 microg
Morphine IV
- 16–65 years: 5 mg IV and, if required, repeat once after 5 minutes, maximum dose 10 mg
- 65 years and over: 2.5 mg IV and, if required, repeat once after 5 minutes, maximum dose 5 mg
Morphine IM
- 16–65 years: 5 mg IM and, if required, repeat once after 60 minutes, maximum dose 10 mg
- 65 years and over: 2.5 mg IM and, if required, repeat once after 60 minutes, maximum dose 5 mg
and/or paracetamol 1000 mg orally once only
and/or ibuprofen 400 mg orally once only
If pain does not improve with medication, escalate as per local CERS protocol.
Nausea and/or vomiting
If nausea and/or vomiting is present, give:
- metoclopramide 10 mg orally or IV/IM once only (over 20 years only)
- or ondansetron 4 mg orally or IV/IM. If symptoms persist after 60 minutes, repeat once, maximum dose 8 mg
- or prochlorperazine 5 mg orally once only or 12.5 mg IV/IM once only
Choice of antiemetic should be determined by cause of symptoms.
Radiology
- If life-threatening or concern for pneumothorax: CXR
Pathology
- FBC, UEC
- Moderate to severe respiratory distress: ABG (if trained) or VBG
- Suspected cardiac cause: troponin
- Warfarinised: INR
- Temp less than 35°C, or 38.5°C and above: take two sets of blood cultures from two separate sites
- If clinically indicated: respiratory viral PCR screen, sputum culture, urinary antigens for pneumococcus and legionella
Medications
The shaded sections in this protocol are only to be used by registered nurses who have completed the required education.
Drag the table right to view more columns or turn your phone to landscape
Drug | Dose | Route | Frequency |
---|---|---|---|
Fentanyl H, R | 16–65 years: 65 years and over: | IV/intranasal | Pain score 7–10 Repeat once if required after 5 minutes to maximum dose |
Ibuprofen H, R | 400 mg | Oral | Pain score 1–10
Once only |
Over 20 years: | Oral/IV/IM | Once only | |
Morphine H, R | 16–65 years:
65 years and over: | Pain score 7–10 | |
IV | Repeat once if required after 5 minutes | ||
IM | Repeat once if required after 60 minutes | ||
4 mg Maximum dose 8 mg | Oral/IV/IM | Repeat once if required after 60 minutes | |
16–65 years:
65 years and over: | Oral | Pain score 4–6 Repeat once if required after 30 minutes to maximum dose | |
Oxygen | 2–15 L/min, device dependent | Inhalation | Continuous |
1000 mg | Oral | Pain score 1–10 Once only | |
5 mg | Oral | Once only | |
OR | |||
12.5 mg | IV/IM | Once only | |
250 mL Maximum dose 1000 mL | IV/intraosseous | Bolus Repeat every 10 minutes (up to 1000 mL) until SBP over 90 mmHg or signs of shock have resolved |
Medications with contraindications or requiring dose adjustment are marked:
- H for patients with known hepatic impairment
- R for patients with known renal impairment.
Escalate to medical or nurse practitioner.
References
- Ahmed A. Approach to the adult with dyspnea in the emergency department. Netherlands: Wolters Kluwer; 2022 [cited 23 Feb 2023]. Available from: https://www.uptodate.com/contents/approach-to-the-adult-with-dyspnea-in-the-emergency-department#
- Atherton JJ, Sindone A, De Pasquale CG, et al. National Heart Foundation of Australia and Cardiac Society of Australia and New Zealand: Australian clinical guidelines for the management of heart failure 2018. Medical Journal of Australia. 2018;209(8):363-9.
- Beasley R, Chien J, Douglas J, et al. Thoracic Society of Australia and New Zealand oxygen guidelines for acute oxygen use in adults: 'Swimming between the flags'. Respirology. 2015 Nov;20(8):1182-91. DOI: 10.1111/resp.12620
- Clinical Excellence Commission. Sepsis tools. NSW, Australia: NSW Health; 2014 [cited 23 Feb 2023]. Available from: https://www.cec.health.nsw.gov.au/keep-patients-safe/sepsis/sepsis-pathways
- Doost A, Alasady M, Scott P. National Heart Foundation of Australia and the Cardiac Society of Australia and New Zealand: Australian Clinical Guidelines for the Diagnosis and Management of Atrial Fibrillation 2018. Heart Lung Circ. 2019 May;28(5):e106-e7. DOI: 10.1016/j.hlc.2018.11.016
- Kuzniar TJ. Assessment of dyspnoea. BMJ Best Practice: BMJ Publishing Group; 2022 [cited 23 Feb 2023]. Available from: https://bestpractice.bmj.com/topics/en-gb/862?locale=pt_BR
- Martin C, Sobolewski K, Bridgeman P, et al. Systemic thrombolysis for pulmonary embolism: a review. Pharmacy and Therapeutics. 2016;41(12):770.
- MIMS Australia. Clinical Resources. Australia: MIMS Australia Pty Ltd; 2022 [cited 2 Feb 2023]. Available from: https://www.mimsonline.com.au.acs.hcn.com.au/Search/Search.aspx
- National Asthma Council. Australian Asthma Handbook The National Guidelines for Health Professionals. Australia: National Asthma Council Australia Ltd; 2022 [cited 23 Feb 2023]. Available from: https://www.asthmahandbook.org.au/
- NSW Emergency Care Institute. Non-invasive ventilation device settings: a brief guide NSW, Australia: Agency for Clinical Innovation; 2013 [cited 23 Feb 2023]. Available from: https://aci.health.nsw.gov.au/__data/assets/pdf_file/0009/273555/niv-device-settings-endorsed-29-august-2013.pdf
- NSW Emergency Care Institute. Pulmonary Thromboembolism- Evaluation Pathway. NSW, Australia: Agency for Clinical Innovation; 2020 [cited 23 February 2023]. Available from: https://aci.health.nsw.gov.au/networks/eci/clinical/clinical-tools/respiratory/pe/pulmonary-thromboembolism-pe---evaluation-pathway
- NSW Emergency Care Institute. Pulmonary Embolism. NSW, Australia: Agency for Clinical Innovation; 2020 [cited 23 February 2023]. Available from: https://aci.health.nsw.gov.au/networks/eci/clinical/clinical-tools/respiratory/pe
- NSW Emergency Care Institute. Pneumonia. NSW, Australia: Agency for Clinical Innovation; 2020 [cited 23 February 2023]. Available from: https://aci.health.nsw.gov.au/networks/eci/clinical/clinical-tools/respiratory/pneumonia
- NSW Emergency Care Institute. Atrial Fibrillation. NSW, Australia: Agency for Clinical Innovation; 2020 [cited 23 February 2023]. Available from: https://aci.health.nsw.gov.au/networks/eci/clinical/clinical-tools/cardiology/atrial-fibrillation
- NSW Emergency Care Institute. Spontaneous Pneumothorax. NSW, Australia: Agency for Clinical Innovation; 2020 [cited 23 February 2023]. Available from: https://aci.health.nsw.gov.au/networks/eci/clinical/clinical-tools/respiratory/spontaneous-pneumothorax
- NSW Health. Australian Medicines Handbook. Australia: Australian Government, NSW; 2022 [cited 13 Apr 2022]. Available from: https://amhonline.amh.net.au.acs.hcn.com.au/
- Raja AS, Greenberg JO, Qaseem A, et al. Evaluation of patients with suspected acute pulmonary embolism: best practice advice from the Clinical Guidelines Committee of the American College of Physicians. Annals of internal medicine. 2015;163(9):701-11.
- Therapeutic Guidelines. Acute Asthma. Australia: Therapeutic Guidelines Limited; 2020 [cited 23 Feb 2023]. Available from: https://tgldcdp.tg.org.au.acs.hcn.com.au/viewTopic?etgAccess=true&guidelinePage=Respiratory&topicfile=asthma-acute-management&guidelinename=Respiratory§ionId=toc_d1e115#toc_d1e115
- Therapeutic Guidelines. Antiemetic drugs in adults. Australia: Therapeutic Guidelines Limited; 2022 [cited 15 Feb 2023]. Available from: https://tgldcdp.tg.org.au.acs.hcn.com.au/topicTeaser?guidelinePage=Gastrointestinal&etgAccess=true#
Evidence informed |
Information was drawn from evidence-based guidelines and a review of latest available research. For more information, see the development process. |
Collaboration |
This protocol was developed by the ECAT Working Group, led by the Agency for Clinical Innovation. The group involved expert medical, nursing and allied health representatives from local health districts across NSW. Consensus was reached on all recommendations included within this protocol. |
Currency | Due for review: Jan 2026. Based on a regular review cycle. |
Feedback | Email ACI-ECIs@health.nsw.gov.au |
Accessed from the Emergency Care Institute website at https://aci.health.nsw.gov.au/ecat/adult/shortness-of-breath